NCT06643897 Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina. Status COMPLETED Phase NA
NCT06640192 Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir Status RECRUITING Phase PHASE2
NCT06630299 Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06630286 Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06613685 Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated Status TERMINATED Phase PHASE2/PHASE3
NCT06582797 Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor Status NOT_YET_RECRUITING Phase NA
NCT06580873 Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT) Status NOT_YET_RECRUITING Phase PHASE4
NCT06554717 Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV Status RECRUITING Phase PHASE2
NCT06544733 Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT06532656 Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 Status RECRUITING Phase PHASE2/PHASE3
NCT06507059 Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals Status RECRUITING Phase PHASE3
NCT06393387 Retrospective Review of DTG/3TC Versus BIC/F/TAF Across a Multi Clinic Infectious Disease Organization in Southeast United States Status COMPLETED Phase N/A
NCT06358885 IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention Status ACTIVE_NOT_RECRUITING Phase NA
NCT06337032 A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments Status RECRUITING Phase PHASE4
NCT06336434 CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Status WITHDRAWN Phase PHASE1/PHASE2
NCT06333808 Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy Status ACTIVE_NOT_RECRUITING Phase PHASE3